PHARMARESEARCH BIO Co., Ltd. Logo

PHARMARESEARCH BIO Co., Ltd.

A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.

217950 | KO

Overview

Corporate Details

ISIN(s):
KR7217950005
LEI:
Country:
South Korea
Address:
강원도 강릉시 사임당로 641-3 -, 강릉시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PHARMARESEARCH BIO Co., Ltd. is a global biopharmaceutical company dedicated to the research, development, manufacturing, and marketing of innovative biological products. A key part of the PharmaResearch group, which specializes in regenerative medicine, the company focuses on creating advanced treatments to improve human health and quality of life. Its R&D pipeline explores novel therapies and biologicals, including toxin-based technologies, contributing to a diverse portfolio that spans pharmaceuticals, medical devices, and cosmetics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-20 00:00
Share Issue/Capital Change
전환청구권행사 (제3회차)
Korean 11.2 KB
2025-04-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-04-23 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.0 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.4 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.0 MB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.4 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 94.3 KB
2024-12-30 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 10.7 KB
2024-12-16 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-11-26 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차)
Korean 8.9 KB
2024-10-29 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.5 KB
2024-10-22 00:00
Legal Proceedings Report
불성실공시법인미지정
Korean 4.6 KB
2024-10-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB

Automate Your Workflow. Get a real-time feed of all PHARMARESEARCH BIO Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PHARMARESEARCH BIO Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PHARMARESEARCH BIO Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

LENZ Therapeutics, Inc. Logo
Develops a prescription eye drop for presbyopia, the age-related loss of near vision.
United States of America
LENZ
Lexaria Bioscience Corp. Logo
Biotech firm with patented technology improving oral drug delivery and absorption.
United States of America
LEXX
Lexeo Therapeutics, Inc. Logo
Develops AAV gene therapies for genetic cardiovascular and Alzheimer's diseases.
United States of America
LXEO
LEXICON PHARMACEUTICALS, INC. Logo
Develops gene-based drugs for chronic diseases, including treatments for heart failure.
United States of America
LXRX
LIFECORE BIOMEDICAL, INC. \DE\ Logo
A CDMO for parenteral drugs, producing injectable-grade sodium hyaluronate (HA).
United States of America
LFCR
Liminatus Pharma, Inc. Logo
Clinical-stage immuno-oncology firm developing cancer therapies targeting the CD47 checkpoint.
United States of America
LIMN
Lineage Cell Therapeutics Inc. Logo
Developing off-the-shelf cell therapies for neurological and ophthalmic conditions.
Israel
LCTX
Lipigon Pharmaceuticals AB Logo
Develops novel drugs for lipid metabolism disorders to reduce cardiovascular disease risk.
Sweden
LPGO
Lipocine Inc. Logo
Biopharma developing oral drugs for metabolic & endocrine disorders using delivery technology.
United States of America
LPCN
Lipum AB Logo
Develops first-in-class antibody treatments for chronic inflammatory diseases like arthritis.
Sweden
LIPUM

Talk to a Data Expert

Have a question? We'll get back to you promptly.